Related content

Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis

By Mancini Fulvia   Tur Rosa   Martinez Francisca   Coroleu Buenaventura   Rodrííguez Ignacio   Barri Pedro N.  

Gynecological Endocrinology, Vol. 27, Iss. 3, 2011-03 ,pp. : 150-155

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization–embryo transfer

By Doldi Nicola   Persico Paola   Di Sebastiano Francesca   Marsiglio Elena   Ferrari Augusto  

Gynecological Endocrinology, Vol. 22, Iss. 5, 2006-05 ,pp. : 235-238

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone Antagonists: Pharmacology and Clinical Use in Women

By Weiss J.M.   Diedrich K.   Ludwig M.  

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 281-291

Adis International

Access to resources Recommend Favorite

Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial

By Eskandar Mamdoh  

Gynecological Endocrinology, Vol. 23, Iss. 10, 2007-10 ,pp. : 551-555

Informa Healthcare

Access to resources Recommend Favorite

Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.

By Cheung A P   Lu J K   Chang R J  

Human Reproduction, Vol. 12, Iss. 6, 1997-06 ,pp. : 1156-1164

Oxford University Press

Access to resources Recommend Favorite